Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA MutationDouglas D. Fang, Todd VanArsdale|PLoS ONE|2013Cited by 44
PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, TalazoparibXia Ding, Todd VanArsdale|Scientific Reports|2022Cited by 14